Patent Assignment
Reel/Frame 031330/0216
Assignment of Assignor's Interest
Recorded: 2013-10-02
Pages: 3
Assignor
DRULAK, MURRAY
Executed: 1997-02-14
Assignee
ANDRULIS PHARMACEUTICALS CORP.
11800 BALTIMORE AVENUE, SUITE 113, BELTSVILLE, MARYLAND, 20705
Covered Property
(1)
Treatment of Cancer with Thalidomide Alone or in Combination with Other Anti-Cancer Agents
Patent:
6,140,346 →
Application:
09/071,813 →
Related Assignments
(3)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Oct 2, 2013
From: ESTATE OF PETER J. ANDRULIS, JR. BY MARILYN W. ANDRULIS, PERSONAL REPRESENTATIVE; PETER J. ANDRULIS, JR. FAMILY TRUST; MARILYN W. ANDRULIS REVOCABLE TRUST
To: ANDRULIS PHARMACEUTICALS CORP.
Reel/Frame 031329/0444 →
Security Interest
Feb 2, 2015
From: MARATHON PATENT GROUP, INC.; IP LIQUIDITY VENTURES
To: DBD CREDIT FUNDING, LLC
Reel/Frame 034873/0156 →
Security Interest
Jan 11, 2017
From: MOTHEYE TECHNOLOGIES, LLC; SYNCHRONICITY IP LLC; TRAVERSE TECHNOLOGIES CORP.; 3D NANOCOLOR CORP.
To: DBD CREDIT FUNDING LLC, AS COLLATERAL AGENT
Reel/Frame 041333/0001 →